logo
  

Roche To Buy Good Therapeutics Conditionally Active PD-1-regulated IL-2 Program

Good Therapeutics Wednesday said Roche Holding AG (RHHBY) has agreed to acquire Good Therapeutics' conditionally active PD-1-regulated IL-2 Program.

The deal also gives Roche an exclusive right to the platform technology for the development of PD-1-regulated IL-2 receptor agonist therapeutics.

As per the deal, Good Therapeutics will receive an upfront payment of $250 million with additional payments based on reaching certain development, regulatory, and commercial targets.

The deal is expected to close in the third quarter of 2022.

"We are excited to bring Good's innovative PD-1-regulated IL-2 program into our existing oncology pipeline, which nicely complements our efforts on next-generation PD-1-targeted IL-2 therapeutics and our broader oncology strategy of providing cancer patients with innovative solutions and improving health outcomes," said James Sabry, Global Head of Pharma Partnering at Roche.

Following the close of the Roche acquisition, the Good Therapeutics team plans to apply the technology for the design of conditionally active therapeutics to other targets in immuno-oncology and beyond in a new company, Bonum Therapeutics.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google, owned by Alphabet Inc., plans to merge its teams working on Maps products and the mapping service Waze with effect from December 9, reports said. The decision to consolidate processes comes as the search giant is facing pressure to streamline operations and cut costs. The restructuring is expected to reduce overlapping work across the Waze and Maps products. The Pentagon announced that up to $9 billion worth of cloud-computing contracts were awarded to Google, Oracle, Amazon, and Microsoft. In a statement, the U.S. Department of Defense said, "The purpose of this contract is to provide the Department of Defense with enterprise-wide, globally available cloud services across all security domains and classification levels..." Juul Labs, an e-cigarette maker, said it has reached settlements with more than 5,000 vaping lawsuits in the United States. The cases were related to personal injury, consumer class action, government entity, and Native American tribes. In a statement, the company said it cannot disclose the settlement amount at this time as part of the settlement and court process.
Follow RTT